Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sulkowski

Showing results (211-220 of 408) with videos related to

Pageof 41
Sort By:
AIDS (London, England)|December 4, 2004
Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavirMark S Sulkowski, Shruti H Mehta, Richard E Chaisson, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|January 1, 1996
Changes of myocardial capillary density in progression of experimental lung emphysemaS Sulkowski, B Musiatowicz, M Sulkowska, et al.
Journal of Viral Hepatitis|August 14, 2009
Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C populationM Rodriguez-Torres, M S Sulkowski, R T Chung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2016
Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infectionJordan J Feld, Ira M Jacobson, Mark S Sulkowski, et al.
Folia Histochemica Et Cytobiologica|February 1, 2002
Proliferating activity in oral dysplastic leasions and squamous cell carcinomasM Sulkowska, W Famulski, I Kasacka, et al.
Roczniki Akademii Medycznej W Bialymstoku (1995)|January 1, 1995
The effect of activated alveolar macrophages on experimental lung emphysema development. I. Protease and antiprotease activities in the culture medium of alveolar macrophagesS Sulkowski, E Skrzydlewska, M Sulkowska, et al.
AIDS (London, England)|October 28, 2005
A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug usersShruti H Mehta, David L Thomas, Mark S Sulkowski, et al.
Polskie Archiwum Medycyny Wewnetrznej|April 1, 1994
[Evaluation of agreement between brushing cytology diagnosis and histology evaluation of biopsy from gastric mucosa based on analysis of 362 cases]J Dziecioł, B Musiałowicz, M Barwijuk-Machała, et al.
Ginekologia Polska|November 18, 2000
[Expression of PCNA antigen in cellular proliferative activity of cervical carcinoma]A Lenczewski, S Terlikowski, M Sulkowska, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2005
Liver enzyme values in injection drug users with chronic hepatitis CS H Mehta, D Netski, M S Sulkowski, et al.
Pageof 41

Showing results (211-220 of 408) with videos related to

Sort By:
Pageof 41
AIDS (London, England)|December 4, 2004
Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavirMark S Sulkowski, Shruti H Mehta, Richard E Chaisson, et al.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|January 1, 1996
Changes of myocardial capillary density in progression of experimental lung emphysemaS Sulkowski, B Musiatowicz, M Sulkowska, et al.
Journal of Viral Hepatitis|August 14, 2009
Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C populationM Rodriguez-Torres, M S Sulkowski, R T Chung, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 31, 2016
Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infectionJordan J Feld, Ira M Jacobson, Mark S Sulkowski, et al.
Folia Histochemica Et Cytobiologica|February 1, 2002
Proliferating activity in oral dysplastic leasions and squamous cell carcinomasM Sulkowska, W Famulski, I Kasacka, et al.
Roczniki Akademii Medycznej W Bialymstoku (1995)|January 1, 1995
The effect of activated alveolar macrophages on experimental lung emphysema development. I. Protease and antiprotease activities in the culture medium of alveolar macrophagesS Sulkowski, E Skrzydlewska, M Sulkowska, et al.
AIDS (London, England)|October 28, 2005
A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug usersShruti H Mehta, David L Thomas, Mark S Sulkowski, et al.
Polskie Archiwum Medycyny Wewnetrznej|April 1, 1994
[Evaluation of agreement between brushing cytology diagnosis and histology evaluation of biopsy from gastric mucosa based on analysis of 362 cases]J Dziecioł, B Musiałowicz, M Barwijuk-Machała, et al.
Ginekologia Polska|November 18, 2000
[Expression of PCNA antigen in cellular proliferative activity of cervical carcinoma]A Lenczewski, S Terlikowski, M Sulkowska, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 14, 2005
Liver enzyme values in injection drug users with chronic hepatitis CS H Mehta, D Netski, M S Sulkowski, et al.
Pageof 41